FDA rule puts generics, brand-name drugs under same labeling procedures

A rule was proposed Friday by the FDA that would authorize makers of generic drugs to update labels in the same way as brand-name drugmakers. "This proposal will help ensure that health care professionals and consumers have access to the latest safety information for the medications they use," Center for Drug Evaluation and Research Director Dr. Janet Woodcock said. "More than 80 percent of prescriptions filled in the U.S. are for generics, so we want to make sure that generic drug companies actively participate with the FDA to ensure that product safety information is accurate and up to date."

View Full Article in:

Bloomberg Businessweek · New York Times (tiered subscription model), The · FDA Voice blog · Wall Street Journal (tiered subscription model), The

Published in Brief: